MedPath

NIACINAMIDE 4% / TRETINOIN 0.05%

NIACINAMIDE 4% / TRETINOIN 0.05%

Approved
Approval ID

87fde6db-944d-e50d-e053-2a95a90a52a4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 3, 2019

Manufacturers
FDA

Sincerus Florida, LLC

DUNS: 080105003

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NIACINAMIDE 4% / TRETINOIN 0.05%

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72934-1164
Product Classification
G
Generic Name
NIACINAMIDE 4% / TRETINOIN 0.05%
Product Specifications
Route of AdministrationTOPICAL
Effective DateMay 3, 2019
FDA Product Classification

INGREDIENTS (2)

NIACINAMIDEActive
Quantity: 4 g in 100 g
Code: 25X51I8RD4
Classification: ACTIB
TRETINOINActive
Quantity: 0.05 g in 100 g
Code: 5688UTC01R
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NIACINAMIDE 4% / TRETINOIN 0.05% - FDA Drug Approval Details